Skip to main content

E-book

Revolutionizing specialty drug management

Get an in-depth assessment of the ways Specialty Fusion™ is revolutionizing specialty drug management. 

A cross-benefit drug management solution

Explore the work being done with Optum® Specialty Fusion and how it’s reshaping the healthcare industry. In a collection of articles, this e-book:

  • Delves into the intricate web of specialty drug management
  • Reveals how Specialty Fusion simplifies the prior authorization process
  • Uncovers the potential cost savings and improved patient outcomes this solution offers

Related healthcare insights

White paper

Drive improved outcomes and lower costs for blood cancers with CAR T therapy

This white paper analyzes CAR T utilization, outcomes and economic impact across commercial and Medicare populations in the Optum Cell and Gene Therapy (CGT) program from 2022–2024.

Article

Whole-person cancer care: 4 strategies for employers and payers

Life after cancer is complex, and survivorship — living with and beyond diagnosis — demands long-term support for mental, physical and financial health.

Article

How transplant care can guide cell and gene therapy management

Payers facing rising CGT costs and complexity can draw on decades of transplant care experience to improve systems for coordination, risk management and patient support.